Harrow Stock

Harrow Forward P/E

The Forward P/E Ratio of Harrow (HROW) as of Aug 7, 2026 is -249.28. In the previous year, Forward P/E Ratio was -73.28 — a change of 240.16% (lower).

Forward P/E

-249.28

YoY

240.16%

Last updated:

Forward P/E Ratio of Harrow is 2026 -249.28 . Forward P/E Ratio of Harrow was 2025 -73.28 . It decreases by 240.16% lower compared to the previous year.
Access this data via the Eulerpool API

Harrow Stock analysis

What does Harrow do? Harrow Health Inc is a healthcare company based in San Diego that specializes in the development, manufacturing, and marketing of innovative medical products. The company was founded in 2012 as Imprimis Pharmaceuticals and has since become a significant player in the healthcare market. Harrow is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Harrow stock

Forward P/E Ratio of Harrow is -249.28 in 2026.

Forward P/E Ratio of Harrow changed from -73.28 to -249.28, representing a 240.16% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Forward P/E Ratio Harrow since 2006 – with annual values, charts, and detailed analysis.

The Forward P/E uses estimated future earnings to value a stock. A lower forward P/E relative to the trailing P/E suggests analysts expect earnings growth.

To evaluate Forward P/E Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Forward P/E Ratio.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Forward P/E Ratio's Harrow with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — Harrow

All Key Metrics — Harrow